Resmed Inc. (RMD) Company Profile & Statistics

Resmed Inc.
RMD
(NYSE)
Closed
178.93
+1.32 (+0.74%)
in:usd•As of: Apr 19, 2024 15:59 UTC -4
Open
179.15
High
179.42
Low
177.00

About Resmed Inc.

CEO

Michael J. Farrell

Headquarters

9001 spectrum center blvd.

san diego, ca 92123, united states

Auditor

KPMG LLP

Employees

10,140

Share Holders

Website

www.resmed.com

Industry

medical specialties

Sector

health technology

Company Overview

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.

Resmed Inc. Statistics

Valuation Measures

Market Capitalization ²	26.32B
Enterprise Value	27.34B
Enterprise Value/EBITDA (ttm)	20.18
Price to Earnings Ratio (ttm)	25.56
Price to Book (mrq)	5.70
Price to Sales (ttm)	5.68
Price to Cash (ytd)	22.26

Profitability

Gross Margin (ttm)	55.10%
Operating Margin (ttm)	22.24%
Profit Margin (ttm)	19.79%
Return on Equity (ttm)	23.86%
Return on Invested Capital (ttm)	15.93%
Return on Assets (ttm)	14.78%

Income Statement

Revenue (ttm)	4.50B
Revenue Per Share (ttm)	30.62
Gross Profit (ttm)	2.48B
EBITDA (ttm)³	1.35B
Net Income Avi to Common (ttm)	890.39M
Diluted EPS (ttm)	6.05

Share Statistics

Beta (5Y Monthly)	0.67
52-Week Change	-18.71%
S&P500 52-Week Change	19.56%
S&P500 Member	Yes
Stock Optionable	Yes
Total Shares Outstanding ¹	147.09M
Dividend Yield	1.10%
Float ⁴	145.31M
% Held by Insiders	1.21%
% Held by Institutions	54.98%

Balance Sheet

Total Cash (mrq)	210.25M
Total Cash Per Share (mrq)	1.43
Total Debt (mrq)	1.23B
Total Debt/Equity (mrq)	27.37%
Current Ratio (mrq)	3.11%
Quick Ratio (mrq)	1.89%
Book Value Per Share (mrq)	30.47

Cash Flow

Operating Cash Flow Per Share (ytd)	3.79
Free Cash Flow (ytd)	505.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Resmed Inc.

Trade With A Regulated Broker